Biotechnology Fund (RYBOX) is an MF managed by Independent / Boutique. Its largest position is AbbVie Inc. (ABBV), representing 7.39% of fund assets.
Biotechnology Fund Portfolio Holdings
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- RYBOX
- Type:
- MF
- Manager:
- Independent / Boutique
- Total Assets:
- —
- Report Date:
- Mar 31, 2026
- Filing Date:
- Jun 1, 2026
| Holding | Weight | Market Value | Shares |
|---|---|---|---|
|
-
AbbVie Inc.
|
7.39% | $9,987,793.27 | 45,923 |
|
-
AMGEN INC
|
5.23% | $7,069,722.05 | 20,093 |
|
-
GILEAD SCIENCES, INC.
|
4.96% | $6,695,613.54 | 48,042 |
|
-
VERTEX PHARMACEUTICALS INC / MA
|
4.01% | $5,411,618.26 | 12,119 |
|
-
REGENERON PHARMACEUTICALS, INC.
|
3.56% | $4,808,911.36 | 6,224 |
|
-
ALNYLAM PHARMACEUTICALS, INC.
|
2.60% | $3,517,809.84 | 10,632 |
|
-
INSMED Inc
|
2.45% | $3,315,695.04 | 20,277 |
|
-
BeOne Medicines Ltd.
|
2.29% | $3,087,003.15 | 10,395 |
|
-
Natera, Inc.
|
2.09% | $2,828,858.55 | 14,145 |
|
-
UNITED THERAPEUTICS Corp
|
2.07% | $2,793,528.78 | 4,711 |
|
-
BIOGEN INC.
|
2.01% | $2,713,833.99 | 14,803 |
|
-
Royalty Pharma plc
|
1.98% | $2,673,799.83 | 55,739 |
|
-
ILLUMINA, INC.
|
1.74% | $2,348,472.78 | 19,053 |
|
-
Revolution Medicines, Inc.
|
1.69% | $2,282,943.75 | 23,475 |
|
-
Moderna, Inc.
|
1.65% | $2,225,954.40 | 43,818 |
|
-
ASTRAZENECA PLC
|
1.60% | $2,164,292.28 | 10,974 |
|
-
ARGENX SE
|
1.60% | $2,162,270.25 | 2,961 |
|
-
INCYTE CORP
|
1.56% | $2,100,476.04 | 22,317 |
|
-
Viatris Inc
|
1.50% | $2,027,486.23 | 150,073 |
|
-
BridgeBio Pharma, Inc.
|
1.47% | $1,987,494.64 | 26,764 |
|
-
Alkermes plc.
|
1.47% | $1,982,564.48 | 56,068 |
|
-
Jazz Pharmaceuticals plc
|
1.46% | $1,975,194.40 | 10,448 |
|
-
NEUROCRINE BIOSCIENCES INC
|
1.42% | $1,913,786.98 | 14,527 |
|
-
Guardant Health, Inc.
|
1.41% | $1,903,376.22 | 20,606 |
|
-
Roivant Sciences Ltd.
|
1.40% | $1,893,904.40 | 68,372 |
|
-
IONIS PHARMACEUTICALS INC
|
1.38% | $1,867,488.30 | 24,870 |
|
-
EXELIXIS, INC.
|
1.29% | $1,741,634.23 | 40,607 |
|
-
Medpace Holdings, Inc.
|
1.26% | $1,699,872.60 | 3,540 |
|
-
BIOMARIN PHARMACEUTICAL INC
|
1.24% | $1,679,899.62 | 29,738 |
|
-
APELLIS PHARMACEUTICALS INC
|
1.22% | $1,653,734.61 | 41,107 |
|
-
ARROWHEAD PHARMACEUTICALS, INC.
|
1.22% | $1,653,399.00 | 26,370 |
|
-
CYTOKINETICS INC
|
1.18% | $1,587,969.63 | 24,093 |
|
-
Vaxcyte, Inc.
|
1.14% | $1,533,116.13 | 26,383 |
|
-
CRISPR Therapeutics AG
|
1.13% | $1,524,808.78 | 32,054 |
|
-
HALOZYME THERAPEUTICS, INC.
|
1.09% | $1,467,876.56 | 22,712 |
|
-
BioNTech SE
|
1.06% | $1,436,211.92 | 16,159 |
|
-
Axsome Therapeutics, Inc.
|
1.02% | $1,381,062.42 | 8,171 |
|
-
Ascendis Pharma A/S
|
1.01% | $1,366,433.02 | 5,974 |
|
-
Cogent Biosciences, Inc.
|
0.99% | $1,337,604.48 | 34,752 |
|
-
ARCELLX INC
|
0.99% | $1,337,078.90 | 11,645 |
|
-
TG THERAPEUTICS, INC.
|
0.96% | $1,303,054.50 | 39,225 |
|
-
PTC THERAPEUTICS, INC.
|
0.96% | $1,290,041.55 | 18,935 |
|
-
Scholar Rock Holding Corp
|
0.94% | $1,272,408.28 | 25,883 |
|
-
MADRIGAL PHARMACEUTICALS, INC.
|
0.90% | $1,219,161.63 | 2,329 |
|
-
Mirum Pharmaceuticals, Inc.
|
0.89% | $1,208,330.40 | 13,080 |
|
-
Protagonist Therapeutics, Inc
|
0.87% | $1,180,269.20 | 11,198 |
|
-
AMICUS THERAPEUTICS INC
|
0.82% | $1,103,008.80 | 76,280 |
|
-
RHYTHM PHARMACEUTICALS, INC.
|
0.78% | $1,057,381.26 | 12,158 |
|
-
APOGEE THERAPEUTICS INC
|
0.75% | $1,015,595.22 | 12,066 |
|
-
Kymera Therapeutics, Inc.
|
0.72% | $970,994.82 | 11,658 |
Advertisement (320x50)